KSF Settlements
The Hon. Colleen McMahon entered a Final Judgment approving a $165 million settlement of Lead Plaintiffs’ claims.
Kahn Swick & Foti, LLC Announces Proposed Settlement of Borgwarner Stockholder Derivative Litigation
The Hon. Lorna G. Schofield entered a Final Judgment approving a $44 million settlement of Plaintiffs’ claims.
The Hon. Mary Kay Vyskocil granted final approval to the shareholder derivative settlement in In re Conduent Incorporated Stockholder Derivative Litigation
The Court preliminarily approved the $165M Blackberry securities class action settlement on June 14, 2022.
The Hon. William J. Martini entered a Final Judgment approving a $10 million settlement of Plaintiffs’ claims
The Hon. Janis Lynn Sammartino grants final approval to the class action settlement in Khoja v. Orexigen Therapeutics, Inc., approving Lead Plaintiff’s $4.8 million recovery for investors.
The Hon. Arthur J. Tarnow entered a final judgment in the securities class action lawsuit Dougherty v. Esperion Therapeutics, Case No. 2:16-cv-10089, approving Lead Plaintiffs’ $18.25 million recovery.
The Court approved the settlement of the stockholder derivative action brought on behalf of Twitter, Inc. (“Twitter”) against several of Twitter’s current and former directors and officers for breach of fiduciary duties.
The Hon. Arthur J. Tarnow entered an Order preliminarily approving a $18,250,000 class action settlement on behalf of all Persons who purchased or otherwise acquired Esperion common stock between August 18, 2015 and September 28, 2015.
On April 22, 2021, the Hon. Janis L. Sammartino entered an Order preliminarily approving a $4,800,000 class action settlement on behalf of all Persons who purchased or otherwise acquired Orexigen publicly-traded securitiesbetween March 3, 2015 and May 12, 2015.
Final judgment and order in the consolidated Health Insurance Innovations Securities Litigation was entered approving a $2.8 million recovery for investors.
Kahn Swick & Foti, LLC Announces Proposed Settlement of Twitter, Inc. Stockholder Derivative Litigation
KSF’s stockholder derivative action was brought on behalf of Twitter, Inc. (“Twitter”) against several of Twitter’s current and former directors and officers for breach of fiduciary duties. On December 17, 2020, plaintiffs were able to secure a settlement providing that Twitter’s board of directors will pay $38 million in cash to Twitter and $8.75 million in attorney fees and court costs.
The Hon. Thomas P. Barber, United States District Court Judge for the Middle District of Florida, entered an Order preliminarily approving a $2,800,000 class action settlement on behalf of all Persons or entities who purchased or otherwise acquired HIIQ publicly-traded securities between August 4, 2017 and September 11, 2017, inclusive.
On November 29, 2020, Vice Chancellor Joseph R. Slights III of the Delaware Court of Chancery granted final approval to the shareholder derivative settlement in In re Fitbit, Inc. Stockholder Derivative Litigation.
The Hon. J. Paul Oetken, United States District Court Judge for the Southern District of New York, entered an Order preliminarily approving a $1,600,000 class action settlement in Intellipharmaceutics Securities Litigation
The Honorable Judge John G. Koeltl entered a final judgment and order approving the Lead Plaintiffs’ $14.75 million recovery for investors in the Eletrobras Securities Litigation.
The Honorable Jon P. McCalla (M.D. Tenn.) entered a final judgment and order in the consolidated securities class action lawsuit captioned Kasper v. AAC Holdings, Inc. et al.
Judge Barbara Lynn entered final judgment in Erica P. John Fund, Inc. v. Halliburton Co., et al. KSF served as Co-Class Counsel in the federal securities class action against oilfield services company and a high-level officer, in which Class Counsel obtained a unanimous decision by the U.S. Supreme Court, ultimately resulted in a cash settlement of $100 million for investors.